Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KSE - Delayed Quote KRW

GC Biopharma Corp. (006280.KS)

Compare
117,900.00
+1,900.00
+(1.64%)
At close: 3:30:30 PM GMT+9

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 440.85B
Earnings -27.29B

Q1'24

Q2'24

Q3'24

Q4'24

0
100B
200B
300B
400B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

168,000.00
196,000.00 Average
117,900.00 Current
210,000.00 High

Earnings Estimate

Currency in KRW Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1188
Avg. Estimate -1,049.15272.492,706.165,011.68
Low Estimate -1,049.15272.49697.32,330
High Estimate -1,049.15272.494,40510,055
Year Ago EPS -----2,3032,706.16

Revenue Estimate

Currency in KRW Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3268
Avg. Estimate 419.4B466.65B1.87T2.03T
Low Estimate 412B459.3B1.82T1.94T
High Estimate 431B474B1.96T2.19T
Year Ago Sales 356.81B417.4B1.68T1.87T
Sales Growth (year/est) 17.54%11.80%11.45%8.48%

Earnings History

Currency in KRW 12/31/2024
EPS Est. -37.78
EPS Actual -2,392
Difference -2,354.22
Surprise % -6,231.39%

EPS Trend

Currency in KRW Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -1,049.15272.492,706.165,011.68
7 Days Ago 102.23598.193,296.475,241.33
30 Days Ago 102.23598.193,286.615,248.95
60 Days Ago 102.23598.192,442.754,562.37
90 Days Ago 102.23598.193,409.95,259.66

EPS Revisions

Currency in KRW Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----1--
Up Last 30 Days ----1--
Down Last 7 Days 11--1
Down Last 30 Days ----12

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
006280.KS ----217.51%85.19%
S&P 500 6.74%5.74%9.21%14.18%
Waiting for permission
Allow microphone access to enable voice search

Try again.